214 related articles for article (PubMed ID: 21209915)
1. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
[TBL] [Abstract][Full Text] [Related]
2. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
[TBL] [Abstract][Full Text] [Related]
3. Concurrent Germline and Somatic Mutations in FLCN and Preliminary Exploration of Its Function: A Case Report.
Wang T; Yang Y; Feng H; Cui B; Lv Z; Zhao W; Zhang X; Ma X
Front Oncol; 2022; 12():877470. PubMed ID: 35664771
[TBL] [Abstract][Full Text] [Related]
4. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways.
Ramirez Reyes JMJ; Cuesta R; Pause A
Front Cell Dev Biol; 2021; 9():667311. PubMed ID: 33981707
[No Abstract] [Full Text] [Related]
5. A central role for regulated protein stability in the control of TFE3 and MITF by nutrients.
Nardone C; Palanski BA; Scott DC; Timms RT; Barber KW; Gu X; Mao A; Leng Y; Watson EV; Schulman BA; Cole PA; Elledge SJ
Mol Cell; 2023 Jan; 83(1):57-73.e9. PubMed ID: 36608670
[TBL] [Abstract][Full Text] [Related]
6. Ciliary localization of folliculin mediated via a kinesin-2-binding motif is required for its functions in mTOR regulation and tumor suppression.
Zhang Y; Liu Y; Dai Y; Ren Y; Bao G; Ai B; Jiang Y
FEBS Lett; 2021 Jan; 595(1):123-132. PubMed ID: 33064845
[TBL] [Abstract][Full Text] [Related]
7. [Expression of SCD1 in TFE3-rRCC and its effect on proliferation and migration].
Dong YH; Liuxu WT; Chen Y; Gan WD; Li DM
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):682-687. PubMed ID: 38619513
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for FLCN RagC GAP activation in MiT-TFE substrate-selective mTORC1 regulation.
Jansen RM; Peruzzo R; Fromm SA; Yokom AL; Zoncu R; Hurley JH
Sci Adv; 2022 Sep; 8(37):eadd2926. PubMed ID: 36103527
[TBL] [Abstract][Full Text] [Related]
9. TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells.
Lv S; Zhang Z; Li Z; Ke Q; Ma X; Li N; Zhao X; Zou Q; Sun L; Song T
J Biol Chem; 2024 Apr; 300(5):107270. PubMed ID: 38599381
[TBL] [Abstract][Full Text] [Related]
10. A Simplified Diagnostic Approach on TFE3 Gene Fusion-Associated Renal Cell Carcinoma.
Akgul M; Cheng L; Idrees M
Arch Pathol Lab Med; 2020 Nov; ():. PubMed ID: 33147320
[No Abstract] [Full Text] [Related]
11. TFE3-RCC of the right kidney in an eight-year-old child.
Wu Y; Xie XL; Xiang B
Asian J Surg; 2024 Mar; ():. PubMed ID: 38521744
[No Abstract] [Full Text] [Related]
12. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris.
Martina JA; Diab HI; Lishu L; Jeong-A L; Patange S; Raben N; Puertollano R
Sci Signal; 2014 Jan; 7(309):ra9. PubMed ID: 24448649
[TBL] [Abstract][Full Text] [Related]
13. Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3.
Betschinger J; Nichols J; Dietmann S; Corrin PD; Paddison PJ; Smith A
Cell; 2013 Apr; 153(2):335-47. PubMed ID: 23582324
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases.
Petit CS; Roczniak-Ferguson A; Ferguson SM
J Cell Biol; 2013 Sep; 202(7):1107-22. PubMed ID: 24081491
[TBL] [Abstract][Full Text] [Related]
16. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
[TBL] [Abstract][Full Text] [Related]
17. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
18. FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation.
Dunlop EA; Seifan S; Claessens T; Behrends C; Kamps MA; Rozycka E; Kemp AJ; Nookala RK; Blenis J; Coull BJ; Murray JT; van Steensel MA; Wilkinson S; Tee AR
Autophagy; 2014 Oct; 10(10):1749-60. PubMed ID: 25126726
[TBL] [Abstract][Full Text] [Related]
19. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
20. Oncotargets in different renal cancer subtypes.
Moch H; Montironi R; Lopez-Beltran A; Cheng L; Mischo A
Curr Drug Targets; 2015; 16(2):125-35. PubMed ID: 25619751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
